about
The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations.[Signification of NT-proBNP in the differential diagnosis of syncope in adults].Neopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patientsOxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathyEvaluation of the intima-media complex in patients with systemic lupus erythematosusDiagnostic contribution of cardiac magnetic resonance in patients with acute coronary syndrome and culprit-free angiograms.Immunosuppressive therapy for heart failure: a guide to patient selection.Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery diseaseComparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).COPeptin for diagnosis and prediction in Acute Coronary Syndrome (COPACS) Study: design and objectives.Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up.Left atrial myxoma in a patient with a biventricular pacemaker.Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.The effect of BMI, serum leptin, and adiponectin levels on prognosis in patients with non-ischaemic dilated cardiomyopathy.Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome.Hospitalization length and prognosis in heart failure patients.Clinical Significance of Viral Genome Persistence in the Myocardium of Patients with Dilated Cardiomyopathy.Common origin of all three coronary arteries from the right sinus of Valsalva - first case study accompanied by mitral valve prolapse and vein anomaly, second case study followed by successful percutaneous coronary intervention of right coronary artTherapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease.Analysis of myocardial infarction time course in women compared with men in Upper Silesia population in 30 day follow-up.Serum free testosterone in men with coronary artery atherosclerosis.[Cardiomyopathies and pregnancy--how often, when to decide to terminate?].Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.Prognostic Factors in Patients with an Implanted Pacemaker after 80 Years of Age in a 4-Year Follow-Up.Quantitative myocardial Blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-elevation myocardial infarction: Proof of concept study.The influence of obstructive sleep breathing disturbances on echocardiographic and pulmonary haemodynamic parameters in patients with dilated cardiomyopathy.Randomized placebo controlled blinded study to assess valsartan efficacy in preventing left ventricle remodeling in patients with dual chamber pacemaker--Rationale and design of the trial.Parathyroid hormone serum concentration in Central European patients with non-ischaemic heart failure as a potential marker of disease severity and poor prognosis.Cost assessment of treatment of acute myocardial infarction and angiographically visible coronary thrombus.[Parathormone and vitamin d in heart failure - theoretical influence on disease development and potential therapy targets].Transcriptional activity of interferon gamma and two subunits of its receptor as molecular markers of myocarditis.Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome.The impact of gender on the frequency of syncope provoking factors and prodromal signs in patients with vasovagal syncope.Implantation of an Andrastent XL in an adult with advanced chronic heart failure due to coarctation of the aorta.[Familial hypertrophic cardiomyopathy--a case report].[Relation between local CMV infection and inflammatory cytokine expressionon in pts sheduled for CABG].[The diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection].Combined Use of High-Sensitive Cardiac Troponin, Copeptin, and the Modified HEART Score for Rapid Evaluation of Chest Pain Patients
P50
Q33164494-28F7C249-7783-4685-9190-BF35BA78CC5AQ33164760-ED8E5347-C6AA-4AD2-9CB5-9A6225E8A87BQ34118314-F9883AED-20C7-4880-A2C2-D9BB35646205Q34481181-91DB47B0-03DF-4CD0-A63F-7D6F18674194Q34821915-5DA1E68D-FB88-4C18-BB86-EF5A225BC9AFQ35135842-57E0DFAC-338E-4453-998A-B0B825EEABC6Q35631430-B3394D67-E0AD-477B-8A57-6371D48D2470Q35648305-52CE9757-FAB2-4F13-9A20-64B08C93A5EEQ36239147-9467FDE3-3651-4D2E-97CC-1559D3527AFCQ37463800-376D9E79-35DE-447A-AB10-911F32C7EF01Q37578579-9E204A6A-6A4A-4B58-97DE-0AC8413B735AQ37584188-A3D8C8A5-4482-431D-B03F-C9B363724FC5Q38864023-0D82AC36-DD4C-4377-846E-E0BEB450CF57Q38931670-4D5863F6-2E1A-4DD1-8A3E-5F66D448DE4BQ38952941-05500AEA-958A-4BDC-AFC6-F3FD52414A3BQ40322606-DA2182D2-CF6B-4BD3-96DE-456E92EE12AAQ40403031-725DCBA4-F60F-4BFE-B135-B0182960F4B5Q40931131-CA1A910A-CFDE-4924-95CF-13E3C7498A45Q42290589-4DE3C01F-E8DD-4AB9-A765-9052691C8C88Q42848061-26B53B23-7AB4-4DE3-BCE6-F3E7D09AE9BEQ43232629-AEC516E4-D1E0-48F0-8931-42F1D5EAAA03Q44450047-D0C61851-A3AC-4FC0-871B-5A0BAFBD7B66Q46310815-90A5FEA7-F7F7-478B-BF88-F596CA83FEC8Q46975120-EB4A6D23-C386-4FCE-90D2-D39E1D8622DCQ47320527-F94863A1-2E0C-494F-97AF-88638FB735ACQ47349535-07BB8107-B1F7-4C30-A360-3BE9D3F198BCQ47608611-9F7B1B39-50DA-40DE-95A1-D9B3B6CBDB69Q47953248-330CFBB2-57AB-4685-BB3F-8E548BE76C15Q48237971-CD3697C8-2109-414B-B1BC-046BC187F4F9Q48295922-645B933F-6633-4B02-B1C9-64FDB20A6F7EQ48521295-CD007291-9E38-4093-A998-8D6830D30220Q50076118-5F51E3C6-E072-483B-968E-D4E40BF4B754Q50605003-37354620-D4BE-4244-8B88-0B87F1AC1082Q51064183-7ECA3CCC-9278-47F2-8A65-7B4C2A235477Q52560862-D79F64A4-D36B-42BF-9C16-1F71D4F1EFB5Q53201878-ABBA46EA-1988-48C3-91D0-5BCD14893CE3Q53743164-5D0D232F-B6EA-4734-A047-34072531D1A8Q54448096-3300EBF9-FDF8-46B4-825D-0B4B7B0D5593Q59593211-37FE46B7-6D33-472B-838F-21DB6E59E0EDQ59809959-C4155D29-AD08-4CD5-A0D9-83CF881AB7A6
P50
description
Polish cardiologist
@en
Pools arts
@nl
cairdeolaí Polannach
@ga
polska lekarka, kardiolog
@pl
հետազոտող
@hy
name
Ewa Nowalany-Kozielska
@ast
Ewa Nowalany-Kozielska
@ca
Ewa Nowalany-Kozielska
@cs
Ewa Nowalany-Kozielska
@en
Ewa Nowalany-Kozielska
@es
Ewa Nowalany-Kozielska
@ga
Ewa Nowalany-Kozielska
@gl
Ewa Nowalany-Kozielska
@hr
Ewa Nowalany-Kozielska
@hsb
Ewa Nowalany-Kozielska
@it
type
label
Ewa Nowalany-Kozielska
@ast
Ewa Nowalany-Kozielska
@ca
Ewa Nowalany-Kozielska
@cs
Ewa Nowalany-Kozielska
@en
Ewa Nowalany-Kozielska
@es
Ewa Nowalany-Kozielska
@ga
Ewa Nowalany-Kozielska
@gl
Ewa Nowalany-Kozielska
@hr
Ewa Nowalany-Kozielska
@hsb
Ewa Nowalany-Kozielska
@it
altLabel
Ewa Emilia Nowalany-Kozielska
@en
Ewa Emilia Nowalany-Kozielska
@pl
prefLabel
Ewa Nowalany-Kozielska
@ast
Ewa Nowalany-Kozielska
@ca
Ewa Nowalany-Kozielska
@cs
Ewa Nowalany-Kozielska
@en
Ewa Nowalany-Kozielska
@es
Ewa Nowalany-Kozielska
@ga
Ewa Nowalany-Kozielska
@gl
Ewa Nowalany-Kozielska
@hr
Ewa Nowalany-Kozielska
@hsb
Ewa Nowalany-Kozielska
@it
P214
P106
P1153
6603172943
P1412
P1559
Ewa Nowalany-Kozielska
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-5977-513X
P735
P7859
viaf-167396141